Skip to main content
GENETIC TECHNOLOGIES LIMITED logo

GENETIC TECHNOLOGIES LIMITED — Investor Relations & Filings

Ticker · GTG ISIN · AU000000GTG7 LEI · 529900YYKY7FRC90M744 ASX Human health and social work activities
Open in API
Filings indexed 1,303 across all filing types
Latest filing 2023-09-10 Regulatory Filings
Country AU Australia
Listing ASX GTG

About GENETIC TECHNOLOGIES LIMITED

https://gtglabs.com/

Genetic Technologies Limited is a molecular diagnostics company focused on the development and commercialization of predictive genetic risk assessment tools. The company specializes in the geneType platform, which integrates clinical risk factors with polygenic risk scores to provide comprehensive risk assessments for various chronic diseases. Its portfolio includes tests for breast cancer, colorectal cancer, prostate cancer, melanoma, type 2 diabetes, and coronary artery disease. By identifying individuals at high risk of developing these conditions, the company enables healthcare providers to implement personalized screening and preventative health strategies. Genetic Technologies Limited serves clinicians and patients globally, aiming to improve health outcomes through early detection and precision medicine.

Recent filings

Filing Released Lang Actions
MRFF Grant Names GTG as Sole Industry Partner 3 pages 147.4KB
Regulatory Filings Classification · 95% confidence The document is an ASX Market Announcement from Genetic Technologies Limited about receiving a Medical Research Future Fund (MRFF) grant for a clinical trial related to multi-cancer genetic risk assessment. It describes the trial's purpose, collaborators, and expected outcomes. There are no financial statements, earnings data, or detailed financial analysis. The document is an announcement of a research grant and trial initiation, not a financial report, regulatory filing, or management discussion. It does not fit categories like Annual Report, Interim Report, Earnings Release, or Capital Update. It is a general regulatory announcement about a grant and research collaboration, best classified under Regulatory Filings (RNS). The document length is 8537 characters, which is substantial but the content is clearly an announcement rather than a report or transcript. Therefore, the most appropriate classification is Regulatory Filings (RNS) with high confidence.
2023-09-10 English
2023 Annual Report and Appendix 4E 175 pages 15.0MB
Regulatory Filings
2023-08-30 English
Appendix 4G and Corporate Governance Statement 27 pages 586.5KB
Governance Information Classification · 100% confidence The document is titled 'Corporate Governance Statement' and contains detailed descriptions of the company's governance policies, board responsibilities, committee structures, director appointments, diversity policies, and performance evaluations. It references adherence to the ASX Corporate Governance Principles and Recommendations and discusses governance practices in detail. There is no indication of financial statements, audit results, earnings data, or other financial reporting content. The document is comprehensive and focused on governance practices rather than being an announcement or a brief summary. Therefore, it fits the category of Governance Information (CGR).
2023-08-30 English
Annual Results Momentum Building on our Commercial Plans 3 pages 117.7KB
Annual Report Classification · 95% confidence The document is an ASX announcement dated 31 August 2023 reporting the annual results for the year ended June 30, 2023. It contains detailed discussion of the company's commercial progress, revenue figures, strategic partnerships, product developments, and future outlook. The text includes financial performance data (revenues and growth percentages) and business highlights typical of an annual financial report. The length of the document (9516 characters) and the presence of substantive financial and operational information indicate this is the actual annual report rather than a brief announcement or summary. There is no indication that this is merely a notice of report publication or a certification. Therefore, the document fits the definition of an Annual Report (10-K equivalent).
2023-08-30 English
Change in substantial holding 5 pages 1.5MB
Major Shareholding Notification Classification · 100% confidence The document is a Form 604 Notice of Change of Interests of Substantial Holder filed under the Corporations Act 2001. It details changes in voting power and relevant interests of a substantial shareholder, The Bank of New York Mellon Corporation and its group entities, in Genetic Technologies Limited. The form includes specifics about previous and present voting power, changes in relevant interests, and associations. This type of filing is a notification of changes in significant share ownership levels, which matches the definition of Major Shareholding Notification (MRQ). The document is not an annual report, earnings release, or any other financial report but a regulatory notice about shareholding changes. The length and content confirm it is not a brief announcement but a formal substantial holder notice.
2023-08-16 English
Updated Investor Presentation - August 2023 26 pages 2.6MB
Investor Presentation Classification · 95% confidence The document is titled 'Genetic Technologies – Investor Update' and is dated August 9, 2023. It contains detailed business updates including strategy, revenue growth, commercial operations, ESG initiatives, collaborations, product portfolios, and market pathways. The content is presented in a slide/presentation format with forward-looking statements and detailed operational highlights. There are no indications that this is a full annual or interim financial report with comprehensive financial statements. Instead, it is a detailed presentation aimed at investors, focusing on business strategy, financial performance highlights, and market positioning. This matches the definition of an Investor Presentation (IP). The document length (15,000 characters) and detailed content support this classification with high confidence.
2023-08-08 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.